Trial country

AustraliaAustriaBelgiumCanadaChinaCzech RepublicDenmarkEgyptFinlandFranceGermanyIrelandIsraelItalyJapanMexicoNetherlandsNew ZealandNorwayPolandRomaniaRussiaSingaporeSouth KoreaSpainSwedenSwitzerlandTaiwanUKUSA Multi-country

Principal investigator

Disease category

Cancer diseasesCardiovascular diseasesGene markingHealthy volunteersInfectious diseasesInflammatory diseasesMonogenic diseasesNeurological diseasesOcular diseases Others

Indication

Clinical phase

Phase IPhase I/IIPhase IIPhase II/IIIPhase IIIPhase IVSingle subject

Trial status

OpenClosedNever initiatedWithdrawnUnder reviewSubmission not completeDuplicate Submission of US-697On clinical holdConditional approvalCanceled

Year approved/initiated

198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012